Transaction DateRecipientSharesTypePriceValue
18th September 2020Venture Investments, Llc Alexandria1,268,795Conversion of derivative$0.00
18th September 2020Venture Investments, Llc Alexandria38,461Open or private purchase$13.00$499,993.00
16th September 2020Atul Pande5,000Exercise of derivative$2.92$14,600.00
16th September 2020Atul Pande5,000Open or private sale$85.00$425,000.00
10th September 2020Andrew Craig Miller5,000Open or private sale$75.52$377,600.00
10th September 2020Andrew Craig Miller5,000Exercise of derivative$7.27$36,350.00
9th September 2020James Healy4,557Open or private purchase$73.75$336,078.75
8th September 2020Troy A. Ignelzi2,000Exercise of derivative$9.20$18,400.00
8th September 2020Troy A. Ignelzi2,000Open or private sale$73.30$146,600.00
8th September 2020James Healy504Open or private purchase$73.00$36,792.00
Karuna Therapeutics
Karuna Therapeutics logo

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company develops treatments for people afflicted with schizophrenia.

Ticker: KRTX
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1771917
Employees: 19
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags